IBOV 175,710.05 ▼ 0.51% IPC MEX 69,711.87 ▲ 0.35% MERVAL 2,848,945 — — USD/BRL5.33▼ 0.22% USD/MXN18.65▼ 0.16% USD/CLP983.77▼ 0.54% USD/COP3,146▼ 0.10% USD/PEN3.45▲ 0.03% USD/ARS1,538— 0.00% USD/UYU40.21▲ 3.50% USD/PYG5,803▲ 4.05% USD/BOB11.97▲ 4.12% USD/DOP61.23▲ 1.88% USD/CRC451.24▲ 2.31% USD/GTQ7.64▲ 3.15% USD/HNL26.87▲ 3.37% USD/NIO36.62▼ 0.02% USD/VES885.90▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69▲ 2.51% USD/TTD6.71▲ 1.96% EUR/BRL5.93▼ 1.15% BRENT 109.58 ▼ 5.38% WTI 100.12 ▼ 1.61% IRON ORE 161.91 — — COPPER 6.65 ▲ 2.24% GOLD 4,073 ▲ 0.85% SILVER 54.49 ▲ 0.70% SOY 1,250 ▲ 0.70% CORN 450.25 ▼ 1.04% WHEAT 614.75 ▼ 0.20% COFFEE 294.35 ▼ 2.19% SUGAR 19.26 ▲ 0.84% ORANGE JUICE 143.20 ▲ 5.45% COTTON 77.90 ▼ 1.47% COCOA 5,581 ▲ 1.66% BEEF 230.73 ▲ 0.33% CATTLE 346.40 ▼ 1.00% LITHIUM 62.43 ▲ 1.89% PETR4 53.31 ▼ 1.06% VALE3 62.88 ▼ 2.33% ITUB4 41.42 ▼ 0.67% BBDC4 15.69 ▼ 1.63% ABEV3 15.40 ▲ 0.20% BBAS3 17.59 ▲ 0.69% B3SA3 15.27 ▲ 1.33% WEGE3 45.78 ▲ 2.81% PRIO3 69.21 ▼ 2.71% SUZB3 47.14 ▼ 0.55% RENT3 31.14 ▼ 1.67% AZZA3 16.72 ▲ 1.15% CSAN3 2.69 ▼ 2.89% RAIZ4 0.34 — 0.00% PCAR3 2.22 ▼ 3.48% GMAT3 3.74 ▲ 2.19% PSSA3 47.75 ▼ 0.89% CVCB3 0.98 — 0.00% POSI3 3.56 ▼ 0.84% SLCE3 16.97 ▼ 2.75% NATU3 5.68 ▼ 3.89% BRKM5 3.80 ▲ 19.50% RANI3 7.34 ▼ 0.54% CSNA3 4.76 ▼ 4.99% IBOV 175,710.05 ▼ 0.51% IPC MEX 69,711.87 ▲ 0.35% MERVAL 2,848,945 — — USD/BRL 5.34 ▼ 1.32% USD/MXN 18.69 ▲ 0.62% USD/CLP 983.47 ▼ 0.57% USD/COP 3,149 ▲ 3.06% USD/PEN 3.45 ▲ 0.17% USD/ARS 1,537 ▼ 0.28% USD/UYU 40.21 ▲ 3.57% USD/PYG 5,803 ▲ 3.78% USD/BOB 11.97 ▲ 4.93% USD/DOP 60.54 ▲ 1.83% USD/CRC 451.24 ▲ 2.13% USD/GTQ 7.64 ▲ 3.23% USD/HNL 26.87 ▲ 3.37% USD/NIO 36.62 ▲ 2.81% USD/VES 885.08 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.63% USD/TTD 6.71 ▲ 2.07% EUR/BRL 5.95 ▲ 7.53% BRENT 109.58 ▼ 5.38% WTI 100.12 ▼ 1.61% IRON ORE 161.91 — — COPPER 6.65 ▲ 2.24% GOLD 4,073 ▲ 0.85% SILVER 54.49 ▲ 0.70% SOY 1,250 ▲ 0.70% CORN 450.25 ▼ 1.04% WHEAT 614.75 ▼ 0.20% COFFEE 294.35 ▼ 2.19% SUGAR 19.26 ▲ 0.84% ORANGE JUICE 143.20 ▲ 5.45% COTTON 77.90 ▼ 1.47% COCOA 5,581 ▲ 1.66% BEEF 230.73 ▲ 0.33% CATTLE 346.40 ▼ 1.00% LITHIUM 62.43 ▲ 1.89% PETR4 53.31 ▼ 1.06% VALE3 62.88 ▼ 2.33% ITUB4 41.42 ▼ 0.67% BBDC4 15.69 ▼ 1.63% ABEV3 15.40 ▲ 0.20% BBAS3 17.59 ▲ 0.69% B3SA3 15.27 ▲ 1.33% WEGE3 45.78 ▲ 2.81% PRIO3 69.21 ▼ 2.71% SUZB3 47.14 ▼ 0.55% RENT3 31.14 ▼ 1.67% AZZA3 16.72 ▲ 1.15% CSAN3 2.69 ▼ 2.89% RAIZ4 0.34 — 0.00% PCAR3 2.22 ▼ 3.48% GMAT3 3.74 ▲ 2.19% PSSA3 47.75 ▼ 0.89% CVCB3 0.98 — 0.00% POSI3 3.56 ▼ 0.84% SLCE3 16.97 ▼ 2.75% NATU3 5.68 ▼ 3.89% BRKM5 3.80 ▲ 19.50% RANI3 7.34 ▼ 0.54% CSNA3 4.76 ▼ 4.99%
since 2009
Wednesday, October 28, 2026

Covid-19 Brazil

Brazil Could Lose US$336 Billion if Vaccination in Emerging Countries is Restricted, Says ICC

By · January 25, 2021 · 2 min read

RIO DE JANEIRO, BRAZIL – A study commissioned by the International Chamber of Commerce (ICC) estimates that Brazil could have an economic cost of tens of billions of dollars depending on the pace of vaccination against the Covid-19 pandemic.

This cost could be as high as US$224 billion (R$1.2 trillion) if all emerging markets were able to vaccinate only half of their populations. The cost rises to US$336 billion if access is restricted throughout 2021.

A study commissioned by the International Chamber of Commerce (ICC) estimates that Brazil could have an economic cost of tens of billions of dollars depending on the pace of vaccination against the Covid-19 pandemic.
A study commissioned by the International Chamber of Commerce (ICC) estimates that Brazil could have an economic cost of tens of billions of dollars depending on the pace of vaccination against the Covid-19 pandemic.
RT
Ask Rio Times
Latin American markets, currencies and companies.
Open the full Ask Rio Times →

According to the ICC, losses do not depend on whether or not the country imposes a lockdown.

The ICC notes that while other analyses have highlighted the economic costs of nationalism with respect to the vaccine, its study is the first to incorporate both supply and demand shocks at the sectoral level for an open economy operating in global value chains.

The assessment is that if emerging and developing nations do not have the vaccine, or have it too late, they will not be able to rebound adequately, nor will they provide the intermediate goods required in developed countries, for instance.

The study concludes that the world economy as a whole could lose up to US$9.2 trillion if developing countries are unable to access anti-covid vaccines.

The economic cost for developed countries, in the absence of multilateral coordination to ensure vaccine access and distribution, ranges between US$203 billion and US$4.5 trillion, according to the study.

For the US, the economic cost of prioritizing immunization of its population, without ensuring equitable access for developing economies, is estimated to range from US$45 billion to US$1.38 trillion.

For the United Kingdom, the cost would range between US$ 8.5 billion and US$146 billion. For Germany, it would be between US$14 billion and US$248 billion.

The message that the World Health Organization (WHO) has tried to rapidly spread is that wealthy countries should have an interest in expediting vaccination in developing nations too, and prevent disruptions in global trade and supply chains.

 

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error · Editorial responsibility: Matthias Camenzind, Editor-in-Chief

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.